Table 1.
Summary of the clinical, morphological, and genetic features of 18 cases with the diagnosis of high-grade/large B-cell lymphoma with 11q aberration
Clinicopathological features |
High-grade B-cell lymphoma with 11q aberration/large B-cell lymphoma with 11q aberration |
---|---|
Age |
Median 22.5 years (range 7–72 years) |
Sex | M:F 2.5:1 |
Localization | |
-Tonsils | 4 cases (22%) |
-Lymph nodes | 7 cases (38%) |
-Abdominal mass | 5 cases (28%) |
-Ovary | 1 case (6%) |
-Not available | 1 case (6%) |
Clinical stage | |
- Stage 1/2 | 12 cases (67%) |
- Stage 3/4 | 6 cases (33%) |
Cytology | |
-Blastoid | 4 cases (22%) |
-Intermediate, Burkitt like | 9 cases (50%) |
-Large | 1 case (6%) |
-Not available | 4 cases (22%) |
Immunophenotype | |
-CD10 | 17 cases (94%) |
-BCL6 | 17 cases (94%) |
-LMO2* | 7 cases (38%) |
-BCL2 | 1 case (6%) |
-MYC** | 18 cases (100%) |
-MUM1 | 2 cases (12%) |
FISH | |
-11q gain | 18 cases (100%) |
-11q loss | 18 cases (100%) |
-IGH::MYC | 0 (0%) |
-BCL2 | 0 (0%) |
-BCL6 | 0 (0%) |
*Performed only on 15 cases in which the material was available; M male, F female